CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This study will evaluate the efficacy and safety of different doses of EVO756 in adults with moderate to severe atopic dermatitis.
Phase 2
Murfreesboro, Tennessee, United States and 11 other locations
The purpose of this study is to measure how well taking lebrikizumab alone works for participants with fewer places on the body with eczema ...
Phase 4
Goodlettsville, Tennessee, United States and 74 other locations
This study is being conducted to establish the efficacy of ruxolitinib cream in participants with moderate AD who had an inadequate response to, or a...
Phase 3
Murfreesboro, Tennessee, United States and 96 other locations
B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical Medications in patients aged 12 years and older who have moderate to seve...
Phase 3
Murfreesboro, Tennessee, United States and 541 other locations
The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.
Phase 3
Hermitage, Tennessee, United States and 555 other locations
The objective of this study is to assess the efficacy and safety of upadacitinib for the treatment of adolescent and adult participants with moderate...
Phase 3
Murfreesboro, Tennessee, United States and 194 other locations
This is a multicenter, double-blind, Long-Term Extension (LTE) study to evaluate the long-term safety and efficacy of APG777 in patients with moderat...
Phase 2
Nashville, Tennessee, United States and 31 other locations
The goal of this clinical trial is to learn if CGB-500 works to treat atopic dermatitis in participants ages 12 and older. The goal is also to learn...
Phase 2
Nashville, Tennessee, United States and 15 other locations
This is an interventional, randomized, parallel group, treatment, Phase IIb, double blind, 4-arm study to assess the effect of pegylated-recombinant-...
Phase 2
Murfreesboro, Tennessee, United States and 118 other locations
The objective of this study is to assess the efficacy and safety of upadacitinib combined with topical corticosteroids (TCS) for the treatment of ado...
Phase 3
Goodlettsville, Tennessee, United States and 193 other locations
Clinical trials
Research sites
Resources
Legal